Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

Slide Presentation of the 2007 Annual Meeting of AHRQ

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Comparative Effectiveness

Text Description is below the image.
  • What is J&J's position on comparative effectiveness?
    • Help establish the value of treatments
    • Promote a more quality-focused cost-effective health system
    • Help physicians and patients make better decisions
    • Be a way for manufacturers to differentiate products
    • However, it is not the "silver bullet" as it will not automatically solve our cost and quality challenges
  • How should information from CE research be used?
    • Should inform medical decisions, not replace medical judgment with treatment formulas
    • Will need to reconcile "average" population effects and with impacts on individuals that reflect differences in side effects, intolerance, noncompliance, and quality of life

Previous Slide Previous Slide         Contents         Next Slide Next Slide


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care